1217 — China Innovation Investment Balance Sheet
0.000.00%
Last trade - 00:00FinancialsSpeculativeMicro CapNeutral
- HK$128.02m
- -HK$9.14m
- -HK$2.07m
- 33
- 94
- 45
- 62
Annual balance sheet for China Innovation Investment, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 383 | 394 | 372 | 341 | 332 |
| Net Total Receivables | 2.57 | 1.45 | 5.02 | 1.62 | 1.64 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 387 | 397 | 378 | 344 | 335 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | 0.463 | 2.23 | 1.34 | 0.831 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 685 | 712 | 656 | 613 | 564 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.27 | 12.2 | 1.21 | 1.21 | 0.77 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.27 | 12.2 | 2.6 | 1.68 | 0.77 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 684 | 700 | 654 | 611 | 563 |
| Total Liabilities & Shareholders' Equity | 685 | 712 | 656 | 613 | 564 |
| Total Common Shares Outstanding |